FdaApplication
NDA 206323
Identifiers
- fda_app_no: NDA206323
Properties
| Property | Value |
|---|---|
| applicant_name | MAINPOINTE PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2015-06-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TUXARIN ER | CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE | 8MG;54.3MG | TABLET, EXTENDED RELEASE;ORAL |
1 product